Reports

Industry Research Reports

Polysaccharide Hemostatic Powder- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Polysaccharide Hemostatic Powder- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-01-13

Pages: 106 Pages

Report ld: 3499384

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Polysaccharide Hemostatic Powder Market Size(US$)

den_QYR1
cagr

CAGR 2025-2031

7.8%

marketSize

Market Size,2031

USD 451

Million

Market Snapshot

Market Size in 2025 (Value)
US$ 287 million
Market Forecast in 2031(Value)
US$ 451 million
CAGR
7.8%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Polysaccharide Hemostatic Powder was estimated to be worth US$ 269 million in 2024 and is forecast to a readjusted size of US$ 451 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.

A polysaccharide hemostatic powder can be used as an adjunctive hemostat to facilitate control of bleeding from capillary, venous or arteriolar vessels to address low-grade intraoperative bleeding.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment. Polysaccharide Hemostatic Powder is an innovative hemostatic product formulated primarily with natural polysaccharides, known for their ability to promote blood clotting and wound healing. As awareness of health and a demand for natural and safe products continue to rise, the market has shown a significant interest in Polysaccharide Hemostatic Powder. Its distinctive hemostatic mechanism and low irritability make it an ideal choice in fields such as surgical procedures, trauma management, and emergency care. In recent years, the clinical efficacy of Polysaccharide Hemostatic Powder has been well-documented, gradually establishing it as a trusted option among medical institutions and consumers alike.

This report aims to provide a comprehensive presentation of the global market for Polysaccharide Hemostatic Powder, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Polysaccharide Hemostatic Powder by region & country, by Type, and by Application.

The Polysaccharide Hemostatic Powder market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polysaccharide Hemostatic Powder.

MARKET SEGMENTATION

By Company

  • EndoClot Plus
  • Baxter
  • Hemostasis, LLC
  • Singclean Medical Products
  • Johnson & Johnson
  • BD
  • Zhonghui Shengxi
  • Beijing Tech-Bio-Med Medical Equipment Co.,Ltd.
  • Saikesaisi Holdings Group
  • Boz Medical

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Polysaccharide Hemostatic Powder
  • Absorbable Modified Polymer

Segment by Application

  • Hospital
  • Clinic
  • Other

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

marn_i1

Chapter 2: Detailed analysis of Polysaccharide Hemostatic Powder manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

marn_i1

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

marn_i1

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

marn_i1

Chapter 5: Sales, revenue of Polysaccharide Hemostatic Powder in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

marn_i1

Chapter 6: Sales, revenue of Polysaccharide Hemostatic Powder in country level. It provides sigmate data by Type, and by Application for each country/region.

marn_i1

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

marn_i1

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

marn_i1

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Market Overview

1.1 Polysaccharide Hemostatic Powder Product Introduction

1.2 Global Polysaccharide Hemostatic Powder Market Size Forecast

1.2.1 Global Polysaccharide Hemostatic Powder Sales Value (2020-2031)

1.2.2 Global Polysaccharide Hemostatic Powder Sales Volume (2020-2031)

1.2.3 Global Polysaccharide Hemostatic Powder Sales Price (2020-2031)

1.3 Polysaccharide Hemostatic Powder Market Trends & Drivers

1.3.1 Polysaccharide Hemostatic Powder Industry Trends

1.3.2 Polysaccharide Hemostatic Powder Market Drivers & Opportunity

1.3.3 Polysaccharide Hemostatic Powder Market Challenges

1.3.4 Polysaccharide Hemostatic Powder Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Competitive Analysis by Company

2.1 Global Polysaccharide Hemostatic Powder Players Revenue Ranking (2024)

2.2 Global Polysaccharide Hemostatic Powder Revenue by Company (2020-2025)

2.3 Global Polysaccharide Hemostatic Powder Players Sales Volume Ranking (2024)

2.4 Global Polysaccharide Hemostatic Powder Sales Volume by Company Players (2020-2025)

2.5 Global Polysaccharide Hemostatic Powder Average Price by Company (2020-2025)

2.6 Key Manufacturers Polysaccharide Hemostatic Powder Manufacturing Base and Headquarters

2.7 Key Manufacturers Polysaccharide Hemostatic Powder Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Polysaccharide Hemostatic Powder

2.9 Polysaccharide Hemostatic Powder Market Competitive Analysis

2.9.1 Polysaccharide Hemostatic Powder Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Polysaccharide Hemostatic Powder Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polysaccharide Hemostatic Powder as of 2024)

2.10 Mergers & Acquisitions, Expansion

muLu

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Polysaccharide Hemostatic Powder

3.1.2 Absorbable Modified Polymer

3.2 Global Polysaccharide Hemostatic Powder Sales Value by Type

3.2.1 Global Polysaccharide Hemostatic Powder Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Polysaccharide Hemostatic Powder Sales Value, by Type (2020-2031)

3.2.3 Global Polysaccharide Hemostatic Powder Sales Value, by Type (%) (2020-2031)

3.3 Global Polysaccharide Hemostatic Powder Sales Volume by Type

3.3.1 Global Polysaccharide Hemostatic Powder Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Polysaccharide Hemostatic Powder Sales Volume, by Type (2020-2031)

3.3.3 Global Polysaccharide Hemostatic Powder Sales Volume, by Type (%) (2020-2031)

3.4 Global Polysaccharide Hemostatic Powder Average Price by Type (2020-2031)

muLu

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Clinic

4.1.3 Other

4.2 Global Polysaccharide Hemostatic Powder Sales Value by Application

4.2.1 Global Polysaccharide Hemostatic Powder Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Polysaccharide Hemostatic Powder Sales Value, by Application (2020-2031)

4.2.3 Global Polysaccharide Hemostatic Powder Sales Value, by Application (%) (2020-2031)

4.3 Global Polysaccharide Hemostatic Powder Sales Volume by Application

4.3.1 Global Polysaccharide Hemostatic Powder Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Polysaccharide Hemostatic Powder Sales Volume, by Application (2020-2031)

4.3.3 Global Polysaccharide Hemostatic Powder Sales Volume, by Application (%) (2020-2031)

4.4 Global Polysaccharide Hemostatic Powder Average Price by Application (2020-2031)

muLu

5 Segmentation by Region

5.1 Global Polysaccharide Hemostatic Powder Sales Value by Region

5.1.1 Global Polysaccharide Hemostatic Powder Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Polysaccharide Hemostatic Powder Sales Value by Region (2020-2025)

5.1.3 Global Polysaccharide Hemostatic Powder Sales Value by Region (2026-2031)

5.1.4 Global Polysaccharide Hemostatic Powder Sales Value by Region (%), (2020-2031)

5.2 Global Polysaccharide Hemostatic Powder Sales Volume by Region

5.2.1 Global Polysaccharide Hemostatic Powder Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Polysaccharide Hemostatic Powder Sales Volume by Region (2020-2025)

5.2.3 Global Polysaccharide Hemostatic Powder Sales Volume by Region (2026-2031)

5.2.4 Global Polysaccharide Hemostatic Powder Sales Volume by Region (%), (2020-2031)

5.3 Global Polysaccharide Hemostatic Powder Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Polysaccharide Hemostatic Powder Sales Value, 2020-2031

5.4.2 North America Polysaccharide Hemostatic Powder Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Polysaccharide Hemostatic Powder Sales Value, 2020-2031

5.5.2 Europe Polysaccharide Hemostatic Powder Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Polysaccharide Hemostatic Powder Sales Value, 2020-2031

5.6.2 Asia Pacific Polysaccharide Hemostatic Powder Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Polysaccharide Hemostatic Powder Sales Value, 2020-2031

5.7.2 South America Polysaccharide Hemostatic Powder Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Polysaccharide Hemostatic Powder Sales Value, 2020-2031

5.8.2 Middle East & Africa Polysaccharide Hemostatic Powder Sales Value by Country (%), 2024 VS 2031

muLu

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Polysaccharide Hemostatic Powder Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Polysaccharide Hemostatic Powder Sales Value

6.2.1 Key Countries/Regions Polysaccharide Hemostatic Powder Sales Value, 2020-2031

6.2.2 Key Countries/Regions Polysaccharide Hemostatic Powder Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Polysaccharide Hemostatic Powder Sales Value, 2020-2031

6.3.2 United States Polysaccharide Hemostatic Powder Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Polysaccharide Hemostatic Powder Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Polysaccharide Hemostatic Powder Sales Value, 2020-2031

6.4.2 Europe Polysaccharide Hemostatic Powder Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Polysaccharide Hemostatic Powder Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Polysaccharide Hemostatic Powder Sales Value, 2020-2031

6.5.2 China Polysaccharide Hemostatic Powder Sales Value by Type (%), 2024 VS 2031

6.5.3 China Polysaccharide Hemostatic Powder Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Polysaccharide Hemostatic Powder Sales Value, 2020-2031

6.6.2 Japan Polysaccharide Hemostatic Powder Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Polysaccharide Hemostatic Powder Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Polysaccharide Hemostatic Powder Sales Value, 2020-2031

6.7.2 South Korea Polysaccharide Hemostatic Powder Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Polysaccharide Hemostatic Powder Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Polysaccharide Hemostatic Powder Sales Value, 2020-2031

6.8.2 Southeast Asia Polysaccharide Hemostatic Powder Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Polysaccharide Hemostatic Powder Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Polysaccharide Hemostatic Powder Sales Value, 2020-2031

6.9.2 India Polysaccharide Hemostatic Powder Sales Value by Type (%), 2024 VS 2031

6.9.3 India Polysaccharide Hemostatic Powder Sales Value by Application, 2024 VS 2031

muLu

7 Company Profiles

7.1 EndoClot Plus

7.1.1 EndoClot Plus Company Information

7.1.2 EndoClot Plus Introduction and Business Overview

7.1.3 EndoClot Plus Polysaccharide Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 EndoClot Plus Polysaccharide Hemostatic Powder Product Offerings

7.1.5 EndoClot Plus Recent Development

7.2 Baxter

7.2.1 Baxter Company Information

7.2.2 Baxter Introduction and Business Overview

7.2.3 Baxter Polysaccharide Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Baxter Polysaccharide Hemostatic Powder Product Offerings

7.2.5 Baxter Recent Development

7.3 Hemostasis, LLC

7.3.1 Hemostasis, LLC Company Information

7.3.2 Hemostasis, LLC Introduction and Business Overview

7.3.3 Hemostasis, LLC Polysaccharide Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Hemostasis, LLC Polysaccharide Hemostatic Powder Product Offerings

7.3.5 Hemostasis, LLC Recent Development

7.4 Singclean Medical Products

7.4.1 Singclean Medical Products Company Information

7.4.2 Singclean Medical Products Introduction and Business Overview

7.4.3 Singclean Medical Products Polysaccharide Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Singclean Medical Products Polysaccharide Hemostatic Powder Product Offerings

7.4.5 Singclean Medical Products Recent Development

7.5 Johnson & Johnson

7.5.1 Johnson & Johnson Company Information

7.5.2 Johnson & Johnson Introduction and Business Overview

7.5.3 Johnson & Johnson Polysaccharide Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Johnson & Johnson Polysaccharide Hemostatic Powder Product Offerings

7.5.5 Johnson & Johnson Recent Development

7.6 BD

7.6.1 BD Company Information

7.6.2 BD Introduction and Business Overview

7.6.3 BD Polysaccharide Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 BD Polysaccharide Hemostatic Powder Product Offerings

7.6.5 BD Recent Development

7.7 Zhonghui Shengxi

7.7.1 Zhonghui Shengxi Company Information

7.7.2 Zhonghui Shengxi Introduction and Business Overview

7.7.3 Zhonghui Shengxi Polysaccharide Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 Zhonghui Shengxi Polysaccharide Hemostatic Powder Product Offerings

7.7.5 Zhonghui Shengxi Recent Development

7.8 Beijing Tech-Bio-Med Medical Equipment Co.,Ltd.

7.8.1 Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Company Information

7.8.2 Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Introduction and Business Overview

7.8.3 Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Polysaccharide Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Polysaccharide Hemostatic Powder Product Offerings

7.8.5 Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Recent Development

7.9 Saikesaisi Holdings Group

7.9.1 Saikesaisi Holdings Group Company Information

7.9.2 Saikesaisi Holdings Group Introduction and Business Overview

7.9.3 Saikesaisi Holdings Group Polysaccharide Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 Saikesaisi Holdings Group Polysaccharide Hemostatic Powder Product Offerings

7.9.5 Saikesaisi Holdings Group Recent Development

7.10 Boz Medical

7.10.1 Boz Medical Company Information

7.10.2 Boz Medical Introduction and Business Overview

7.10.3 Boz Medical Polysaccharide Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)

7.10.4 Boz Medical Polysaccharide Hemostatic Powder Product Offerings

7.10.5 Boz Medical Recent Development

muLu

8 Industry Chain Analysis

8.1 Polysaccharide Hemostatic Powder Industrial Chain

8.2 Polysaccharide Hemostatic Powder Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Polysaccharide Hemostatic Powder Sales Model

8.5.2 Sales Channel

8.5.3 Polysaccharide Hemostatic Powder Distributors

muLu

9 Research Findings and Conclusion

muLu

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Polysaccharide Hemostatic Powder Market Trends
Table 2. Polysaccharide Hemostatic Powder Market Drivers & Opportunity
Table 3. Polysaccharide Hemostatic Powder Market Challenges
Table 4. Polysaccharide Hemostatic Powder Market Restraints
Table 5. Global Polysaccharide Hemostatic Powder Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Polysaccharide Hemostatic Powder Revenue Market Share by Company (2020-2025)
Table 7. Global Polysaccharide Hemostatic Powder Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Polysaccharide Hemostatic Powder Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Polysaccharide Hemostatic Powder Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers Polysaccharide Hemostatic Powder Manufacturing Base and Headquarters
Table 11. Key Manufacturers Polysaccharide Hemostatic Powder Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Polysaccharide Hemostatic Powder
Table 13. Global Polysaccharide Hemostatic Powder Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polysaccharide Hemostatic Powder as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Polysaccharide Hemostatic Powder Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Polysaccharide Hemostatic Powder Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Polysaccharide Hemostatic Powder Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Polysaccharide Hemostatic Powder Sales Market Share in Value by Type (2020-2025)
Table 20. Global Polysaccharide Hemostatic Powder Sales Market Share in Value by Type (2026-2031)
Table 21. Global Polysaccharide Hemostatic Powder Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Polysaccharide Hemostatic Powder Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Polysaccharide Hemostatic Powder Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Polysaccharide Hemostatic Powder Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Polysaccharide Hemostatic Powder Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Polysaccharide Hemostatic Powder Price by Type (2020-2025) & (US$/Unit)
Table 27. Global Polysaccharide Hemostatic Powder Price by Type (2026-2031) & (US$/Unit)
Table 28. Global Polysaccharide Hemostatic Powder Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Polysaccharide Hemostatic Powder Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Polysaccharide Hemostatic Powder Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Polysaccharide Hemostatic Powder Sales Market Share in Value by Application (2020-2025)
Table 32. Global Polysaccharide Hemostatic Powder Sales Market Share in Value by Application (2026-2031)
Table 33. Global Polysaccharide Hemostatic Powder Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Polysaccharide Hemostatic Powder Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global Polysaccharide Hemostatic Powder Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global Polysaccharide Hemostatic Powder Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Polysaccharide Hemostatic Powder Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Polysaccharide Hemostatic Powder Price by Application (2020-2025) & (US$/Unit)
Table 39. Global Polysaccharide Hemostatic Powder Price by Application (2026-2031) & (US$/Unit)
Table 40. Global Polysaccharide Hemostatic Powder Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Polysaccharide Hemostatic Powder Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Polysaccharide Hemostatic Powder Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Polysaccharide Hemostatic Powder Sales Value by Region (2020-2025) & (%)
Table 44. Global Polysaccharide Hemostatic Powder Sales Value by Region (2026-2031) & (%)
Table 45. Global Polysaccharide Hemostatic Powder Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global Polysaccharide Hemostatic Powder Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global Polysaccharide Hemostatic Powder Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global Polysaccharide Hemostatic Powder Sales Volume by Region (2020-2025) & (%)
Table 49. Global Polysaccharide Hemostatic Powder Sales Volume by Region (2026-2031) & (%)
Table 50. Global Polysaccharide Hemostatic Powder Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global Polysaccharide Hemostatic Powder Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions Polysaccharide Hemostatic Powder Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Polysaccharide Hemostatic Powder Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Polysaccharide Hemostatic Powder Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Polysaccharide Hemostatic Powder Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions Polysaccharide Hemostatic Powder Sales Volume, (2026-2031) & (K Units)
Table 57. EndoClot Plus Company Information
Table 58. EndoClot Plus Introduction and Business Overview
Table 59. EndoClot Plus Polysaccharide Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. EndoClot Plus Polysaccharide Hemostatic Powder Product Offerings
Table 61. EndoClot Plus Recent Development
Table 62. Baxter Company Information
Table 63. Baxter Introduction and Business Overview
Table 64. Baxter Polysaccharide Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. Baxter Polysaccharide Hemostatic Powder Product Offerings
Table 66. Baxter Recent Development
Table 67. Hemostasis, LLC Company Information
Table 68. Hemostasis, LLC Introduction and Business Overview
Table 69. Hemostasis, LLC Polysaccharide Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. Hemostasis, LLC Polysaccharide Hemostatic Powder Product Offerings
Table 71. Hemostasis, LLC Recent Development
Table 72. Singclean Medical Products Company Information
Table 73. Singclean Medical Products Introduction and Business Overview
Table 74. Singclean Medical Products Polysaccharide Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Singclean Medical Products Polysaccharide Hemostatic Powder Product Offerings
Table 76. Singclean Medical Products Recent Development
Table 77. Johnson & Johnson Company Information
Table 78. Johnson & Johnson Introduction and Business Overview
Table 79. Johnson & Johnson Polysaccharide Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Johnson & Johnson Polysaccharide Hemostatic Powder Product Offerings
Table 81. Johnson & Johnson Recent Development
Table 82. BD Company Information
Table 83. BD Introduction and Business Overview
Table 84. BD Polysaccharide Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. BD Polysaccharide Hemostatic Powder Product Offerings
Table 86. BD Recent Development
Table 87. Zhonghui Shengxi Company Information
Table 88. Zhonghui Shengxi Introduction and Business Overview
Table 89. Zhonghui Shengxi Polysaccharide Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Zhonghui Shengxi Polysaccharide Hemostatic Powder Product Offerings
Table 91. Zhonghui Shengxi Recent Development
Table 92. Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Company Information
Table 93. Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Introduction and Business Overview
Table 94. Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Polysaccharide Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Polysaccharide Hemostatic Powder Product Offerings
Table 96. Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Recent Development
Table 97. Saikesaisi Holdings Group Company Information
Table 98. Saikesaisi Holdings Group Introduction and Business Overview
Table 99. Saikesaisi Holdings Group Polysaccharide Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Saikesaisi Holdings Group Polysaccharide Hemostatic Powder Product Offerings
Table 101. Saikesaisi Holdings Group Recent Development
Table 102. Boz Medical Company Information
Table 103. Boz Medical Introduction and Business Overview
Table 104. Boz Medical Polysaccharide Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Boz Medical Polysaccharide Hemostatic Powder Product Offerings
Table 106. Boz Medical Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Polysaccharide Hemostatic Powder Downstream Customers
Table 110. Polysaccharide Hemostatic Powder Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Polysaccharide Hemostatic Powder Product Picture
Figure 2. Global Polysaccharide Hemostatic Powder Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Polysaccharide Hemostatic Powder Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Polysaccharide Hemostatic Powder Sales Volume (2020-2031) & (K Units)
Figure 5. Global Polysaccharide Hemostatic Powder Sales Price (2020-2031) & (US$/Unit)
Figure 6. Polysaccharide Hemostatic Powder Report Years Considered
Figure 7. Global Polysaccharide Hemostatic Powder Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Polysaccharide Hemostatic Powder Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Polysaccharide Hemostatic Powder Revenue in 2024
Figure 10. Polysaccharide Hemostatic Powder Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Polysaccharide Hemostatic Powder Picture
Figure 12. Absorbable Modified Polymer Picture
Figure 13. Global Polysaccharide Hemostatic Powder Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Polysaccharide Hemostatic Powder Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Polysaccharide Hemostatic Powder Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 16. Global Polysaccharide Hemostatic Powder Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Polysaccharide Hemostatic Powder Price by Type (2020-2031) & (US$/Unit)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Clinic
Figure 20. Product Picture of Other
Figure 21. Global Polysaccharide Hemostatic Powder Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 22. Global Polysaccharide Hemostatic Powder Sales Value Market Share by Application, 2024 & 2031
Figure 23. Global Polysaccharide Hemostatic Powder Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 24. Global Polysaccharide Hemostatic Powder Sales Volume Market Share by Application, 2024 & 2031
Figure 25. Global Polysaccharide Hemostatic Powder Price by Application (2020-2031) & (US$/Unit)
Figure 26. North America Polysaccharide Hemostatic Powder Sales Value (2020-2031) & (US$ Million)
Figure 27. North America Polysaccharide Hemostatic Powder Sales Value by Country (%), 2024 VS 2031
Figure 28. Europe Polysaccharide Hemostatic Powder Sales Value, (2020-2031) & (US$ Million)
Figure 29. Europe Polysaccharide Hemostatic Powder Sales Value by Country (%), 2024 VS 2031
Figure 30. Asia Pacific Polysaccharide Hemostatic Powder Sales Value, (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Polysaccharide Hemostatic Powder Sales Value by Region (%), 2024 VS 2031
Figure 32. South America Polysaccharide Hemostatic Powder Sales Value, (2020-2031) & (US$ Million)
Figure 33. South America Polysaccharide Hemostatic Powder Sales Value by Country (%), 2024 VS 2031
Figure 34. Middle East & Africa Polysaccharide Hemostatic Powder Sales Value, (2020-2031) & (US$ Million)
Figure 35. Middle East & Africa Polysaccharide Hemostatic Powder Sales Value by Country (%), 2024 VS 2031
Figure 36. Key Countries/Regions Polysaccharide Hemostatic Powder Sales Value (%), (2020-2031)
Figure 37. Key Countries/Regions Polysaccharide Hemostatic Powder Sales Volume (%), (2020-2031)
Figure 38. United States Polysaccharide Hemostatic Powder Sales Value, (2020-2031) & (US$ Million)
Figure 39. United States Polysaccharide Hemostatic Powder Sales Value by Type (%), 2024 VS 2031
Figure 40. United States Polysaccharide Hemostatic Powder Sales Value by Application (%), 2024 VS 2031
Figure 41. Europe Polysaccharide Hemostatic Powder Sales Value, (2020-2031) & (US$ Million)
Figure 42. Europe Polysaccharide Hemostatic Powder Sales Value by Type (%), 2024 VS 2031
Figure 43. Europe Polysaccharide Hemostatic Powder Sales Value by Application (%), 2024 VS 2031
Figure 44. China Polysaccharide Hemostatic Powder Sales Value, (2020-2031) & (US$ Million)
Figure 45. China Polysaccharide Hemostatic Powder Sales Value by Type (%), 2024 VS 2031
Figure 46. China Polysaccharide Hemostatic Powder Sales Value by Application (%), 2024 VS 2031
Figure 47. Japan Polysaccharide Hemostatic Powder Sales Value, (2020-2031) & (US$ Million)
Figure 48. Japan Polysaccharide Hemostatic Powder Sales Value by Type (%), 2024 VS 2031
Figure 49. Japan Polysaccharide Hemostatic Powder Sales Value by Application (%), 2024 VS 2031
Figure 50. South Korea Polysaccharide Hemostatic Powder Sales Value, (2020-2031) & (US$ Million)
Figure 51. South Korea Polysaccharide Hemostatic Powder Sales Value by Type (%), 2024 VS 2031
Figure 52. South Korea Polysaccharide Hemostatic Powder Sales Value by Application (%), 2024 VS 2031
Figure 53. Southeast Asia Polysaccharide Hemostatic Powder Sales Value, (2020-2031) & (US$ Million)
Figure 54. Southeast Asia Polysaccharide Hemostatic Powder Sales Value by Type (%), 2024 VS 2031
Figure 55. Southeast Asia Polysaccharide Hemostatic Powder Sales Value by Application (%), 2024 VS 2031
Figure 56. India Polysaccharide Hemostatic Powder Sales Value, (2020-2031) & (US$ Million)
Figure 57. India Polysaccharide Hemostatic Powder Sales Value by Type (%), 2024 VS 2031
Figure 58. India Polysaccharide Hemostatic Powder Sales Value by Application (%), 2024 VS 2031
Figure 59. Polysaccharide Hemostatic Powder Industrial Chain
Figure 60. Polysaccharide Hemostatic Powder Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Polysaccharide Hemostatic Powder market size from 2025 to 2031?zhanKai
The annual compound growth rate of the global Polysaccharide Hemostatic Powder market is 7.8% 2025 to 2031.
What was the global market size of Polysaccharide Hemostatic Powder in 2025?shouQi
Which companies rank high in the global Polysaccharide Hemostatic Powder market?shouQi
What was the global market size of Polysaccharide Hemostatic Powder in 2031?shouQi
Which region is expected to have the highest market share?shouQi
den_biaoTiZhungShi

Related Reports

Polysaccharide Hemostatic Powder- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-01-13

Pages: 106 Pages

Report ld: 3499384

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Online

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Online

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Online

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now